Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
298.35
+9.56 (3.31%)
Mar 19, 2026, 3:55 PM EDT - Market open
PRAX Stock Forecast
Stock Price Forecast
The 15 analysts that cover PRAX stock have a consensus rating of "Strong Buy" and an average price target of $572.13, which forecasts a 91.76% increase in the stock price over the next year. The lowest target is $83 and the highest is $1,245.
Price Target: $572.13 (+91.76%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PRAX stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 9 | 10 | 10 | 9 | 9 |
| Buy | 3 | 2 | 2 | 3 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 13 | 14 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Buy Initiates $500 | Buy | Initiates | $500 | +67.59% | Feb 24, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $282 → $305 | Hold | Maintains | $282 → $305 | +2.23% | Feb 20, 2026 |
| Baird | Baird | Buy Maintains $275 → $433 | Buy | Maintains | $275 → $433 | +45.13% | Feb 20, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $500 → $700 | Strong Buy | Maintains | $500 → $700 | +134.62% | Feb 20, 2026 |
| Wedbush | Wedbush | Sell Maintains $95 → $130 | Sell | Maintains | $95 → $130 | -56.43% | Feb 20, 2026 |
Financial Forecast
Revenue This Year
4.61M
Revenue Next Year
299.72M
from 4.61M
Increased by 6,395.88%
EPS This Year
-15.37
from -13.48
EPS Next Year
-11.18
from -15.37
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 12.7M | 662.8M | |||
| Avg | 4.6M | 299.7M | |||
| Low | n/a | 95.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 14,265.8% | |||
| Avg | - | 6,395.9% | |||
| Low | - | 1,962.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -12.29 | -5.27 | |||
| Avg | -15.37 | -11.18 | |||
| Low | -21.72 | -17.20 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.